Elicio Therapeutics, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
Elicio Therapeutics, Inc. (ELTX) reported Adjustments to Additional Paid in Capital, Warrant Issued of $641.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-08-13
- Elicio Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-06-30 was $641.00K.
- Elicio Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- Elicio Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2020-12-31 was $0.00.
- Elicio Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2020-09-30 was $1.93M.
- Elicio Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2025 was $641.00K.
- Elicio Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2020 was $3.10M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2025-12-31 | $641.00K 10-K · filed 2026-03-12 | |||
| 2025-06-30 | $641.00K 10-Q · filed 2026-08-13 | |||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-15 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $1.93M derived: sum of 2 quarters · filed 2022-03-30 | $2.94M derived: sum of 3 quarters · filed 2022-03-30 | $3.10M 10-K · filed 2022-03-30 |
| 2020-09-30 | $1.93M 10-Q · filed 2021-11-12 | $2.94M derived: sum of 2 quarters · filed 2021-11-12 | $3.10M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $1.02M 10-Q · filed 2021-08-12 | $1.17M derived: sum of 2 quarters · filed 2021-08-12 | ||
| 2020-03-31 | $151.00K 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |